Jared Kaltwasser | Authors


As CLL Approaches Expand, Sequencing Questions Arise

September 22, 2022

Doctors and patients who can stick with a regimen despite relatively minor adverse event will ultimately have more options later in the treatment journey, which could then lead to better long-term outcomes in chronic lymphocytic leukemia.